A new method of etiopathogenetic treatment of patients with influenza
https://doi.org/10.21886/2219-8075-2020-11-3-34-39
Abstract
Purpose: to develop an effective and safe method for the etiopathogenetic treatment of influenza patients, aimed at increasing the effectiveness of the existing standard treatment using the antiviral drug oseltamivir.
Materials and methods: 150 patients with a verified diagnosis of influenza were taken under observation. All of the participants were divided by randomization into two groups (n1 = 77, n2 = 73) which had the same initial clinical and laboratory characteristics. I group’s patients received standard antiviral therapy using oseltamivir. Patients of the II group at the same time as oseltamivir additionally received an aqueous solution of rehydron for 5 days. All patients underwent determination of the acidity of the mucous membrane of the oropharynx immediately before the start of antiviral therapy and immediately after its completion.
Results: patients additionally receiving rehydron had a more rapid leveling of the main symptoms of influenza and a decrease in the frequency of its complications compared with people who received only standard treatment.
Conclusions: the developed method of etiopathogenetic treatment of patients with influenza is characterized by a proven level of effectiveness, which is associated with the corrective effect of rehydron on the acid-base balance of the mucous membranes of the respiratory tract. The data obtained in the course of the study indicate not only the absolute scientific novelty of the developed method, but also its applied significance for practical public health.
About the Authors
Yu. M. AmbalovRussian Federation
Yury М. Ambalov, Dr. Sci. (Med.), professor, Head of the department of infectious diseases
Rostov-on-Don
D. V. Sizyakin
Russian Federation
Dmitry V. Sizyakin, Honored Doctor of the Russian Federation, Dr. Sci. (Med.), professor, chief physician
Rostov-on-Don
D. V. Dontsov
Russian Federation
Denis V. Dontsov, Dr. Sci. (Med.), associate professor, professor of the Department of Infectious Diseases
Rostov-on-Don
A. A. Kurdin
Russian Federation
Alexey A. Kurdin, postgraduate student, Department of Infectious Diseases
Rostov-on-Don
A. P. Kovalenko
Russian Federation
Anna P. Kovalenko, Cand. Sci. (Med.), associate professor, associate professor of the department of infectious diseases
Rostov-on-Don
M. A. Proydakov
Mikhail A. Proydakov, Cand. Sci. (Med.), associate professor, associate professor of the department of infectious diseases
Rostov-on-Don
N. I. Mamedova
Russian Federation
Nonna I. Mamedova, Cand. Sci. (Med.), associate professor, associate professor of the department of infectious diseases
Rostov-on-Don
D. S. Ryazanova
Daria S. Ryazanova, head of the student group at the Department of Infectious Diseases
Rostov-on-Don
References
1. Kudaeva F, Speechley M, Klar N, Schieir O, Bartlett SJ, et al. Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort. ACR Open Rheumatol. 2019;1(1):63-69. https://doi.org/10.1002/acr2.1009. eCollection 2019 Mar.
2. Brooke-Pearce F, Demertzi E. Introduction of Cobas Liat Influenza A/B for rapid point-of-care diagnosis of influenza infection in an acute trust. J. Infect. Prev. 2019;20(6):297-300. https://doi.org/10.1177/1757177419853342
3. Sawada S, Okutani F, Kobayashi T. Comprehensive Detection of Respiratory Bacterial and Viral Pathogens in the Middle Ear Fluid and Nasopharynx of Pediatric Patients With Acute Otitis Media. Pediatr. Infect. Dis. J. 2019;38(12);1199-1203. https://doi.org/10.1097/INF.0000000000002486
4. Ilyushina NA, Komatsu TE, Ince WL, Donaldson EF, Lee N, et al. Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies. Virol. J. 2019;16(1):149. https://doi.org/10.1186/s12985-019-1258-X
5. Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infectious Diseases. 2019;19(1):964. https://doi.org/10.1186/s12879-019-4592-0
6. Charbonneau DH, James LN. FluView and FluNet: Tools for Influenza Activity and Surveillance. Medical Reference Services Quarterly. 2019;38(4):358-368. https://doi.org/10.1080/02763869.2019.1657734
7. Kain T, Fowler R. Preparing intensive care for the next pandemic influenza. Critical Care. 2019;23(1):337. https://doi.org/10.1186/s13054-019-2616-1
8. Hartmann W, Brunn ML, Stetter N, Gagliani N, Muscate F, et al. Helminth Infections Suppress the Efficacy of Vaccination against Seasonal Influenza. Cell. Rep. 2019;29(8):2243-2256. https://doi.org/10.1016/j.celrep.2019.10.051
9. Mahowald M., Shahan B., Forbes D. Respiratory Conditions: Lower Respiratory Tract Infections. FP Essent. 2019;486:19- 25. PMID: 31710454.
10. Kurdin A.A., Ambalov Yu.M., Kovalenko A.P., Pshenichnaya N.U., Dontsov D.V., et al. Clinical and pathogenetic role of reducing skin pH and polymorphisms of the INFL3 and INFL4 genes in patients with influenza and other acute respiratory viral infections. Infektsionnyye bolezni. 2017;15(S1):151-152. (in Russ.) eLIBRARY ID: 34869920
11. Chernukh A.M. Microcirculation. Moscow:Meditsina;1984. (in Russ.)
Review
For citations:
Ambalov Yu.M., Sizyakin D.V., Dontsov D.V., Kurdin A.A., Kovalenko A.P., Proydakov M.A., Mamedova N.I., Ryazanova D.S. A new method of etiopathogenetic treatment of patients with influenza. Medical Herald of the South of Russia. 2020;11(3):34-39. (In Russ.) https://doi.org/10.21886/2219-8075-2020-11-3-34-39